Patients being treated with high-dose steroids in the setting of GVHD, had significantly fewer activated CMV-specific T lymphocytes, both CD8+/IFN-γ+ and CD4+/IFN-γ+ at all developmental stages after allo-SCT. Here, CD8A is linked to graft versus host disease.